King Chulalongkorn Memorial Hospital is a public general and tertiary referral hospital in Bangkok, Thailand. It is operated by the Thai Red Cross Society, and serves as the teaching hospital for the Faculty of Medicine, Chulalongkorn University and Srisavarindhira Thai Red Cross Institute of Nursing.

There are 1,435 beds in King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University.

During the past decade, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University" are "Asymptomatic Conditions" (1 trials), "Basal Ganglia Diseases" (1 trials), "Brain Diseases" (1 trials), "Central Nervous System Diseases" (1 trials) and "Emergencies" (1 trials). Many other conditions were trialed in "King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University" in a lesser frequency.

Most popular intervention types in "King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University" are "Drug" (4 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "0 mg Induction ONLY" (1 trials), "150 mg Induction/Chronic" (1 trials), "450 mg Induction/Chronic" (1 trials), "50 mg Induction/Chronic" (1 trials) and "Alectinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University" are 6 trials for "All" genders.

Currently, there are NaN active trials in "King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".